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RNA interference (RNAi) is an important antiviral defense response in plants and invertebrates; however, evidences for its con-
tribution to mammalian antiviral defense are few. In the present study, we demonstrate the anti-dengue virus role of RNAi in
mammalian cells. Dengue virus infection of Huh 7 cells decreased the mRNA levels of host RNAi factors, namely, Dicer, Drosha,
Ago1, and Ago2, and in corollary, silencing of these genes in virus-infected cells enhanced dengue virus replication. In addition,
we observed downregulation of many known humanmicroRNAs (miRNAs) in response to viral infection. Using reversion-of-
silencing assays, we further showed that NS4B of all four dengue virus serotypes is a potent RNAi suppressor. We generated a
series of deletion mutants and demonstrated that NS4Bmediates RNAi suppression via its middle and C-terminal domains,
namely, transmembrane domain 3 (TMD3) and TMD5. Importantly, the NS4B N-terminal region, including the signal sequence
2K, which has been implicated in interferon (IFN)-antagonistic properties, was not involved in mediating RNAi suppressor ac-
tivity. Site-directed mutagenesis of conserved residues revealed that a Phe-to-Ala (F112A) mutation in the TMD3 region resulted
in a significant reduction of the RNAi suppression activity. The green fluorescent protein (GFP)-small interfering RNA (siRNA)
biogenesis of the GFP-silenced line was considerably reduced by wild-type NS4B, while the F112Amutant abrogated this reduc-
tion. These results were further confirmed by in vitro dicer assays. Together, our results suggest the involvement of miRNA/
RNAi pathways in dengue virus establishment and that dengue virus NS4B protein plays an important role in the modulation of
the host RNAi/miRNA pathway to favor dengue virus replication.
RNA interference (RNAi) is a conserved, sequence-specific,gene-regulatorymechanism that plays an important role(s) in
host cell defense against viral pathogens and transposons in
plants, insects, and nematodes (1, 2). A number of reports have
implied a direct role of RNAi in regulating viral infections in
mammalian cells (3). Furthermore, it was found thatmutations in
components of RNAi machinery enhanced the replication of ve-
sicular stomatitis virus (VSV), influenza virus, and human immu-
nodeficiency virus (HIV) in mammalian cells (3). Viruses in turn
have evolvedmechanisms that counteract this host cell defense by
encoding factors known as RNAi suppressors (4). The suppressor
proteins and noncoding viral RNAs can inhibit the RNAi
(microRNA [miRNA]/small interfering RNA [siRNA]) pathway
through different mechanisms (5–7). Suppression of RNAi by vi-
ral proteins was first discovered in plants. In 1998, the Baulcombe
group showed convincingly the suppression of trans-gene silenc-
ing by HC-Pro of potato virus Y (PVY) and the 2b protein of
cucumber mosaic virus (CMV2b) (8). Subsequently, several viral
suppressors of RNA silencing (VSRs) have been identified in plant
and animal viruses based on their ability to interfere with antiviral
responses and endogenous silencing pathways (5, 7). Amajority of
plant VSRs that have been identified so far have functions other
than suppression of RNAi. These proteins also function as coat
proteins, replicases, movement proteins, and helper components
for viral transmission, replication, or transcriptional regulation,
etc. (6).
Although small RNA-based mechanisms such as RNAi or
miRNA levels have been studied mainly in plant and invertebrate
systems, a recent study by Parameswaran et al. (9) highlighted the
importance of these mechanisms in vertebrate systems. Human
viruses, like plant viruses, encode suppressor proteins or RNAs
that block or modulate the RNAi pathway. The best-studied
mammalian VSRs are Ebola virus VP35, VP30, and VP40 pro-
teins; severe acute respiratory syndrome (SARS) virus 7a accessory
protein; NS1 of influenza A virus; HIV-1 TAT; capsid protein of
hepatitis C virus (HCV); and primate foamy virus Tas (5, 10, 11).
Viral suppressors are diverse within and across kingdoms, exhib-
iting little or no sequence similarities, and they act via different
mechanisms (7). However, a few functional motifs, such as dou-
ble-stranded-RNA (dsRNA)-binding properties and/or GW re-
peatmotifs, have been demonstrated for someVSRs (5, 12, 13). As
mentioned above, VSRs interfere with the endogenous silencing
pathways at different steps. P14 of Pothos latent aureus virus and
p38 of turnip crinkle virus (TCV) inhibit the processing of dsRNA
to siRNAs (14, 15).We have recently shown that flock house virus
B2 protein (FHVB2) binds Dicer, thus preventing dsRNA pro-
cessing (16). p19 of tombusviruses, tomato aspermy cucumovirus
2b protein, and B2 of flock house virus bind siRNAs and sequester
them, thus preventing siRNA/miRNA RISC assembly (17–19).
The prevention of RNA-induced silencing complex (RISC) as-
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sembly also occurs through direct or indirect interactions between
VSRs and the protein components of RISC. Fny-CMV2b protein
physically interacts with the PAZ domain and part of the PIWI
domain of Ago1 (20). A few VSRs use the GW/WG AGO hook to
inhibit siRNA/miRNA-loaded RISC activity and also target the
amplification of antiviral silencing. The vast majority of mamma-
lian viral proteins have not been assessed for potential RNA silenc-
ing suppressor (RSS) activities.
Dengue virus (DV) is the causative agent of dengue fever, the
most prevalent arthropod-borne viral illness in humans, with 50
to 100 million individuals infected annually worldwide. The role
of the host RNAi pathway inmosquitoes upon arboviral infection
has been extensively studied (21). The four serotypes of DV iden-
tified so far (DV1 toDV4) have a single-stranded genomic RNAof
positive polarity that serves as the mRNA for the translation of a
large polyprotein that is co- and posttranslationally processed.
Most, if not all, nonstructural (NS) proteins are involved in the
replication of dengue virus RNA.NS5 is theRNA-dependent RNA
polymerase,NS3 acts as the viral serine protease aswell as theRNA
helicase, and the glycoproteinNS1 probably plays a role at an early
step of viral RNA replication. Little is known about the functions
of the small hydrophobic proteins NS2A, NS4A, and NS4B. NS4B
is the largest of the small hydrophobic NS proteins of dengue
virus, consisting of 248 amino acids (aa). It has been shown to be
part of the viral replication complex and is also implicated in DV
pathogenicity (22, 23).
Relatively little is known about the role of host RNAi/miRNA
pathways, including the role of viral suppressor proteins, in flavi-
virus replication inmammalian cells (24). In the present study, we
showed that DV infection downregulates components of host
RNAi/miRNAmachinery affecting the biogenesis of many known
human miRNAs. Depletion of some of the RNAi components by
siRNA-mediated silencing leads to increases in DV replication.
This indicates that the RNAi machinery is involved in controlling
DV replication in mammalian cells, and one or more of the DV
proteins may counteract this host defense. We identified NS4B as
one of the DV proteins with RNAi suppression activity and
showed that this activity is independent of the interferon (IFN)
inhibition functions of NS4B. Furthermore, the NS4B protein
failed to bind dsRNAbut interfered with dicing activity. Together,
our results provide evidence for the antiviral function of the host
RNAi/miRNAmachinery in dengue virus replication in mamma-
lian cells and implicate NS4B as a VSR that might promote virus
replication.
MATERIALS AND METHODS
Cell lines and viruses. Huh 7 and HEK293T cells were propagated in
Dulbecco’s modified Eagle medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin G
sodium, and 100 g/ml streptomycin sulfate and nonessential amino ac-
ids at 37°C and 5% CO2.
DV2 (P23085 INDI-60) was obtained from the National Institute of
Virology, Pune, India, and propagated in C6/36 mosquito cells. Infected
culture supernatant was used throughout the study.
Gene synthesis and generation of plasmid constructs. To express
NS4B in the Sf21 cell line, the ns4b gene was amplified by using primers
ns4b forward (5=-GGA ATG GGA AAC GAG ATG GGT TTC CTA-3=)
and ns4b reverse (5=-GTC GAC TTA CCT TCT TGT GTT GGT TGT
GTT-3=). Plasmid pTM1.4-DV-2K(1–249) GFP (a kind gift of Ralf Bar-
tenschlager, University of Heidelberg, Heidelberg, Germany) served as a
template for PCR amplification of 2K-NS4B using primers 2k-ns4b for-
ward (5=-GAA ATG GAA TTA ACA CCC CAA GAT AAC CAA TTG-3=)
and 2k-ns4b reverse (5=-GTC GAC TTA CCT TCT TGT GTT GGT TGT
GTT-3=). Additionally, NS4B sequences from the remaining serotypes of
dengue virus were amplified by using the primers listed in Table 1. The
amplified products were ligated into the pIB-V5/His-TOPO vector
(Invitrogen, Grand Island, NY, USA) under the control of a baculovi-
rus early promoter, OpIE2, for better expression levels.
To express NS4B in the leaves of Nicotiana xanthi, the ns4b gene was
amplified by using primers ns4b forward (5=-GGA TCC GGA ATG GGA
AACGAGATGGGT-3=) and ns4b reverse (5=-GAG CTC TTA CCT TCT
TGT GTT GGT TGT-3=) and cloned into the plant binary vector pBI121
under the control of the cauliflower mosaic virus (CaMV) 35S promoter.
To express NS4B proteins of all serotypes and 2K-NS4B in a mamma-
lian cell line (HEK293T), DNAs corresponding to these genes were am-
plified and cloned into pIB-V5/His-TOPO. The cloned fragments were
mobilized into the mammalian expression vector pCDNA 3.1 (Invitro-
gen, Grand Island, NY, USA) under the control of the human cytomega-
lovirus (CMV) promoter.
siRNA transfection and virus infection. Silencer Select siRNAs for
Dicer, Drosha, Ago1, and Ago2 were purchased from Ambion. The
knockdown studies were performed by transfecting 10 nM siRNA duplex
Huh 7 cells by using a reverse transfection protocol with Lipofectamine
2000 (Invitrogen, Grand Island, NY, USA). At 48 h posttransfection, cells
were infected with virus at a multiplicity of infection (MOI) of 10. The
virus was diluted in DMEM containing 2% FBS, and cells were incubated
for 1 h at 37°C on a rocker. After 1 h, cells were washed twice with PBS and
grown in complete growth medium. Cells were collected at 48 h postin-
fection by trypsinization, and the cell pellets were washed once with phos-
phate-buffered saline (PBS) and lysed in TRIzol (Invitrogen, Grand Is-
land, NY, USA) for RNA isolation. RNA was prepared according to the
manufacturer’s protocol. DNase I-treated total RNA was used for quan-
titative real-time PCR (qRT-PCR).
Quantitative real-time PCR. The comparative threshold cycle (CT)
methodwith SYBR greenwas conducted formRNAquantification of host
RNAi factors using primers described previously (25), and viral genomic
RNA was quantitated by using TaqMan primer-probe mix as described
previously (26). Genome copy numbers were normalized to glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. Relative ex-
pression was calculated by using the comparative threshold cyclemethod.
Similarly, miRNA quantifications were performed by using the TaqMan
microRNA assay system according to the manufacturer’s instructions.
Small RNA library preparation and sequencing. Huh 7 cells were
infected with DV2 at an MOI of 10. At 48 h postinfection, the cells were
harvested, and total RNA was extracted by using TRIzol according to the
manufacturer’s protocol. The total RNA of the uninfected and infected
cells was used to prepare a small RNA library using Ture Seq small RNA
library preparation by Illumina Inc. The PCR products of the library cor-
responding to a length of 145 to 160 bpwere considered and sequenced by
using Solexa, a massively parallel sequencing technology.
Analysis of sequence reads for knownmiRNAs. Small 36-nucleotide
(nt) RNA reads were produced by using the Illumina genome analyzer.
Low-quality reads were trimmed with our own perl script. Adaptor se-
quences were accurately clipped with the aid of a dynamic programming
TABLE 1 List of primers for different serotypes of dengue virus ns4b
Dengue virus
serotype Primer sequence of NS4B (5=–3=)a
DV1 GGA ATG GGA AAT GAG ATG GGA TTA CTG GAA (For)
TTA TCT CCT ACC TCC TCC TAG AGA TTT (Rev)
DV3 GGA ATG GGA AAT GAA ATG GGA CTG CTG GAA (For)
TTA TCT TTT TCC TGT TCC AAC TGA TTT (Rev)
DV4 GGA ATG GGA AAC GAG ATG GGG CTG ATT GAA (For)
TTA CCT CCT AGG GGT TTG TGC ATT CTT (Rev)
a For, forward; Rev, reverse.
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algorithm. After elimination of redundancy, sequences of 18 nt and
26 nt were used to create a set of unique reads. The unique reads were
matched to miRBase v19 and mapped to known human miRNAs. Se-
quences that perfectly matched the reported human miRNA sequences
were considered for subsequent analysis.
Generation and overexpression ofNS4Bmutants.To generateNS4B
deletion mutants, ns4b gene segments with transmembrane domain
(TMD) deletions were amplified by using specific primers. The primers
used for the generation of the deletion mutants are listed in Table 2. The
amplified products were ligated into the pIB-V5/His-TOPO vector,
and the orientation of the genes was confirmed by PCR and restriction
analysis.
Conserved and alanine scan mutants in the TMD3 region of the ns4b
gene were constructed by using the QuikChange site-directed mutagene-
sis kit (Agilent Technologies, Santa Clara, CA, USA) according to the
manufacturer’s protocol. Briefly, PCR was performed on the wild-type
(wt) ns4b gene cloned into a pIB-V5/His-TOPO vector using primer pairs
with the corresponding mutation. Pfu Turbo DNA polymerase (Agilent
Technologies, Santa Clara, CA, USA) was used for PCR. The mismatched
oligonucleotides used for site-directed mutagenesis are shown in Table 3.
After amplification, the PCRmixture was subsequently treated with DpnI
enzyme to removemethylated parental DNAprior to transformation into
Escherichia coli XL1B cells. Three clones were selected for each mutant,
and the plasmid from each colony was isolated and sequenced to confirm
the incorporation of the desired mutation. All of the deletion and substi-
tution mutants were further cloned into pCDNA3.1 as described above
for transfection into the HEK293T cell line.
Suppression-of-RNAi assay in the Sf21 cell line. To analyze dengue
virus NS4B suppressor activity in the Sf21 cell line, a previously developed
Sf21 RNAi sensor line (experimental line 1 [green fluorescent protein
{GFP}-silenced cells in which GFP expression levels are reduced to the
minimum by constitutively expressing GFP and short hairpin RNA
{shRNA} of gfp under the control of the same promoter, OpIE2]) was
employed (16). Briefly, Sf21 cells were seeded into 6-well plates in BD
Baculogold TNM-FH insect medium containing 10% fetal bovine serum
with gentamicin and 300g/ml zeocin. The line was transfected with 1g
of plasmid pIB-V5/His-TOPO containing the ns4B gene by using Cellfec-
tin II reagent (Invitrogen, Grand Island, NY, USA) in BD Baculogold
max-XP serum-free medium. After 4 h, the serum-free medium was re-
placed with serum-containing medium, and the cells were allowed to
transiently express NS4B. The vector pIB-V5/His-TOPO was transfected
independently to serve as a control. GFP expression in the transfected
lines was quantified by fluorescence-activated cell sorter (FACS) analysis.
Suppression-of-RNAi assay in plant leaves. The suppression assay in
plant leaves was performed as described previously (27). Briefly, NS4B
was transiently expressed by agroinfiltrating a recombinant pBI121 vector
harboring the ns4B gene into plant tissues of N. xanthi expressing a GFP
reporter gene and GFP shRNA, and the leaves were observed at 8 days
postinfiltration (dpi). As a control, the vector pBI121 was agroinfiltrated
into leaf tissues.
Suppression-of-RNAi assay in a mammalian (HEK293T) cell line.
The suppression assay in a mammalian (HEK293T) cell line was per-
formed as described previously (27). Briefly, HEK293T cells were seeded
into 12-well plates in Dulbecco’s modified Eagle’s medium containing
10% fetal bovine serum. The cells were transfected with 1 g each of the
pSIREN-RetroQ, pSIREN-RetroQ-shRNA gfp, and pSIREN-RetroQ-
shRNA gfp vectors with NS4B/pCDNA3.1 or NS4B deletion/substitu-
tion mutants by using JetPRIME reagent (Polyplus Transfection; BP,
Illkirch, France) in jetPRIME buffer. After 4 h of transfection, the serum-
freemediumwas replaced by serum-supplementedmedium, and the cells
were allowed to transiently express NS4B and/or its deletion as well as
substitution mutants. The GFP expression in the transfected lines was
quantified by FACS analysis.
Flow cytometric (FACS) analysis of various cell lines. The GFP ex-
pression levels in two different cell lines were quantified by FACS analysis.
For the FACS analysis, Sf21 cells or HEK293T cells were washed with
FACS-grade PBS (BDBiosciences) and resuspended in 400l of PBS. The
GFP fluorescence of the cells was determined by FACSCalibur flow cy-
tometry (Becton, Dickinson, Franklin Lakes, NJ, USA). The fluorescence
analysis was performed by using Cellquest software (Becton, Dickinson,
Franklin Lakes, NJ, USA). All the experiments involving quantification of
GFP-fluorescing cells by FACS analysis were carried out three times, and
statistical significance of the results was determined by the use of Student’s
t test.
IFN assay. For the IFN assay, HeLa cells were considered instead of
HEK293T cells. UnlikeHEK293T cells, HeLa cells express TLR3 (Toll-like
receptor 3) on their surface, which can recognize poly(I·C) to stimulate an
IFN response inside the cell. The cells were cotransfected with 100 ng of
pISRE-Luc (a firefly luciferase expression plasmid under the control of the
interferon-stimulated response element [ISRE] promoter) (Agilent Tech-
nologies, Santa Clara, CA, USA) and 500 ng of plasmids encoding wt
NS4B, 2K-NS4B, and domain BC/NS4B. Subsequently, at 24 h posttrans-
fection, cells were transfected with poly(I·C) (20 g/ml) by using Lipo-
fectamine 2000 CD reagent (Invitrogen, Grand Island, NY, USA). The
cells were lysed 7 h after the poly(I·C) treatment, and the luciferase ex-
pression level was determined by using the dual-luciferase reporter assay
(Promega,Madison,WI, USA) according to themanufacturer’s protocol.
Protein purification. NS4B is predicted to be a membrane protein.
The protein was purified in a recombinant manner according to a proto-
col described previously (28). Briefly, protein, expressed in BL21 cells, was
localized in inclusion bodies, which were isolated as described previously
TABLE 3 List of primer sequences used for various substitution
mutants of ns4b
Substitution
mutation Primer sequence (5=–3=)
P104L TCA CAA GTC AAC CTC ATA ACT CTC ACA (For)
TGT GAG AGT TAT GAG GTT GAC TTG TGA (Rev)
P104A TCA CAA GTC AAC GCC ATA ACT CTC ACA (For)
TGT GAG AGT TAT GGC GTT GAC TTG TGA (Rev)
T108I CCC ATA ACT CTC ATA GCA GCT CTT TTC (For)
GAA AAG AGC TGC TAT GAG AGT TAT GGG (Rev)
T108A CCC ATA ACT CTC GCA GCA GCT CTT TTC (For)
GAA AAG AGC TGC TGC GAG AGT TAT GGG (Rev)
F112L ACA GCA GCT CTT CTC TTA TTG GTA GCA (For)
TGC TAC CAA TAA GAG AAG AGC TGC TGT (Rev)
F112A ACA GCA GCT CTT GCC TTA TTG GTA GCA (For)
TGC TAC CAA TAA GGC AAG AGC TGC TGT (Rev)
TABLE 2 List of primer sequences used for generation of ns4b deletion
mutants
Deletion
mutant Primer sequence (5=–3=)
AB GGA ATG GGA AAC GAG ATG GGT TTC CTA (For)
CAG AGC CCA TGT AGT CCT CAT CAT CAA (Rev)
BC GGA ATG GGA CTC GCC ATT GGA TGC TAC TCA (For)
CCT TCT TGT GTT GGT TGT GTT CTT CAT (Rev)
A GGA ATG GGA AAC GAG ATG GGT TTC CTA (For)
GGA TCC TTA AAG GGG AAC TCC GAT GTC CAT (Rev)
B GGA ATG GGA CTC GCC ATT GGA TGC TAC TCA (For)
CAG AGC CCA TGT AGT CCT CAT CAT CAA (Rev)
C GGA ATG GGA TGT GAG GCT TTA ACC TTA GCT (For)
CCT TCT TGT GTT GGT TGT GTT CTT CAT (Rev)
TMD123 GGA ATG GGA AAC GAG ATG GGT TTC CTA (For)
GTC GAC TTA AGT TGG GTT TTT CAT GAT GCC (Rev)
TMD45 GAA ATG GTC GAT GGA ATA ACA GTG ATT (For)
GTC GAC TTA CCT TCT TGT GTT GGT TGT GTT (Rev)
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(28). Purified inclusion bodies were solubilized in 50 mM 3-(cyclohexyl-
amino)-1-propanesulfonic acid (CAPS) buffer (pH 11.0) containing
1.5% N-lauryl sarcosine and 0.3 M NaCl for 30 min, and the solubilized
protein was separated by centrifugation (10,000 g for 30 min). Protein
was purified by affinity chromatography on a His-Trap column, a high-
performance nickel affinity column (Qiagen), using an imidazole gradient
in 50mMCAPS buffer (pH 11.0) containing 0.3%N-lauryl sarcosine and
0.3MNaCl. Protein-containing fractions were pooled, purified to homo-
geneity, and concentrated by ultrafiltration at 3,000  g (Centricon-30
with a cutoff of 10 kDa).
Preparation of gfp dsRNA. For both in vitro RNA-binding and dicing
assays, the substrate, gfp dsRNA, was prepared by using the Riboprobe
Combination System-SP6/T7 RNA polymerase (Promega, Madison, WI,
USA), but for theRNA-binding assay, the substratewas incorporatedwith
[-32P]UTP. At the end of the reaction, the substrate was subjected to
RNase-free DNase I digestion and purified on an IllustraMicroSpin G-25
column (GE Healthcare, Piscataway, NJ, USA).
Electrophoretic mobility shift assay. Electrophoretic mobility shift
assays (EMSAs) were performed at 37°C for 20 min with 32P-labeled
probes (150 bp) (30,000 cpm per reaction) and 3 g of poly(dI·dC)
(Sigma-Aldrich, St. Louis, MO, USA) in 1 binding buffer. The binding
buffer contained 20 mM HEPES (pH 7.5), 1 mM dithiothreitol, 1 mM
EDTA (pH 8.0), 1.5 mM MgCl2, and 4% glycerol in a final volume of 30
l. The RNA-protein complex was resolved on a 6% acrylamide nonde-
naturing gel (prerun for 1 h at 4°C) in 1Tris-borate-EDTA (TBE) buffer
at 200 V at 4°C. Gels were dried and exposed for autoradiography. Scan-
ning was performed by using the Typhoon 9210 variable-mode imager
from Amersham Biosciences.
Northern blotting. Total low-molecular-weight RNA was isolated
from the GFP-expressing, GFP-silenced, and GFP-reverted cells by using
a mirVANA miRNA isolation kit (Ambion, Austin, TX, USA). Ten mi-
crograms of each low-molecular-weight RNAwas resolved by electropho-
resis on a 20% polyacrylamide gel containing 8M urea. RNA was electro-
blotted for 90min at 15V onto aHybond-Nmembrane (GEHealthcare,
Piscataway, NJ, USA) and immobilized by UV cross-linking at 1,200 
100 J. The complementary gfp probe was labeled with [-32P]ATP by
5=-end labeling using T4 kinase and was allowed to hybridize at room
temperature (RT) overnight. The membrane was washed three times in
6 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) with 0.2%
SDS and once in 6 SSC with 0.2% SDS at 42°C and then exposed to a
phosphorimager screen (Amersham Biosciences, USA) overnight and
scanned at 200mwith a Typhoon-9210 instrument (Amersham Biosci-
ences, USA).
In vitro Dicer assay. dsRNA of 900 bp of the GFP gene was tran-
scribed in vitro by using the Riboprobe Combination System-SP6/T7
RNA polymerase (Promega, Madison, WI, USA). dsRNA was digested
into siRNA (22 bp) by recombinant human Dicer (Genlantis) either in
the absence or in the presence of decreasing amounts of recombinant
protein NS4B, F112A (29). Reaction products were loaded onto an
RNase-free 3% agarose gel and stained with ethidium bromide.
RESULTS
RNAi factorsmodulate dengue virus replication in a human cell
line (Huh 7). Although host RNAi machinery has been shown to
restrict dengue virus replication in insect cell lines (30, 31), limited
data are available on the anti-dengue virus response of RNAi ma-
chinery in mammalian cells (24). To examine the role of host
RNAi in dengue virus replication, the main catalytic components
of host RNAi, namely, Dicer, Drosha, Ago1, and Ago2, were
knocked down by the corresponding siRNAs in Huh 7 cells, and
the levels of knockdown were analyzed by qRT-PCR of the corre-
sponding mRNAs in transfected cells (Fig. 1Ai). We then carried
out infection of the knocked-down cells with DV and conse-
quently measured DV RNA from cells at 48 h postinfection. A
6-fold increase in DV genomic RNA levels was observed in the
cases of Drosha, Ago1, and Ago2 knockdowns, and a nearly 2-fold
increase was seen in the case of Dicer at 48 h postinfection (Fig.
1Aii), compared to cells transfected with siRNA corresponding to
a nontarget control (NTC). We further assessed the effect of DV
infection on the host RNAi pathway by measuring the mRNA
levels of these components in DV-infected cells. As shown in Fig.
1B, we observed a65% reduction in the levels of these mRNAs,
suggesting a negative regulation of RNAi machinery by DV infec-
tion. These data support the notion that downregulation of RNAi
factors helps dengue virus multiplication.
Similar results were observed in the case of West Nile virus
(WNV) replication upon siRNA knockdown of RNAi compo-
nents. As shown by our findings, there was an enhancement of
WNV replication in the cases of Drosha and Ago1 knockdowns
(Fig. 1B), although the levels were not high compared to levels of
dengue virus replication. These results indicated that RNAi ma-
chinery modulates dengue virus replication in mammalian cells,
and the pattern may be conserved among flaviviruses.
Host response to dengue virus infection. The fact that Dicer,
Drosha, Ago1, and Ago2 knockdowns impacted viral replication
in mammalian cells (Fig. 1) suggested that both the cellular RNAi
and miRNA pathways might be influenced by viral infection in
mammalian cells. Since miRNAs have been shown to play an im-
portant role(s) in cellular development, metabolism, and prolif-
eration, it is likely that the profile of host miRNAs might alter to
cope with viral pathogenesis (11). Therefore, we examined the
humanmiRNA responses to dengue virus infection by examining
the changes in the host miRNA profile in cells infected with DV at
48 h postinfection. The population of small RNAs extracted from
both the uninfected and infected cells was sequenced separately by
using the Illumina next generation sequencing (NGS) platform.
The total number of reads was normalized to 1 million for each
sample for analysis purposes. The NGS data analysis revealed that
the abundance of a majority of known human microRNAs had
changed following DV infection. Of the total (151) known mi-
croRNAs randomly examined, 143 (94.7%) were downregulated,
3 (1.9%) (hsa-miR-149-5p, hsa-mir-204-5p, and hsa-miR-375)
were upregulated, and 5 did not change. These results are not
unexpected in view of the general downregulation of drosha and
dicer levels following DV infection. A few of the downregulated
miRNAs are displayed in Fig. 2Ai to iv, and these results were once
again confirmed by stem-loop qRT-PCR analysis for a few of these
miRNAs, namely, hsa-miR-10b-5p, hsa-miR-21-5p, hsa-miR-
125a-5p, hsa-miR-148a-3p, and hsa-miR-375 (Fig. 2B). In addi-
tion, we performed stem-loop qRT analysis of some human
miRNAs upon siRNA knockdown of RNAi components in Huh 7
cells. As seen from our results (Fig. 2C), similar reductions in
miRNA levels were observed compared to changes in the miRNA
profile upondengue virus infection (Fig. 1B and 2C). These results
clearly indicate that the host miRNA/siRNA pathway plays an im-
portant role in controlling viral replication in mammalian cell
lines.
Dengue virus NS4B is a viral RNAi suppressor protein. Plant
viruses have been shown to suppress the RNAi/miRNA pathway
by producing virus-encoded RNAi suppressor proteins (32). A
number of approaches that involve transient/stable expression of
virus-encoded proteins in an RNAi sensor line expressing the re-
porter genes have been used to analyze viral suppressor proteins
(33, 34). We have used similar approaches to test the RNAi sup-
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pressor activity of a number of viral proteins (16, 27). In the pres-
ent study, we analyzed the NS4B protein for its RNAi suppressor
activity. NS4B was selected based on its previously demonstrated
role in alpha/beta interferon signaling inhibition (22, 23, 35). To
assess the RNAi suppressor function of NS4B, we used a previ-
ously established Sf21 RNAi sensor line (experimental line 1) that
was used to screen RNAi suppression properties of FHVB2 (16).
This cell line is particularly useful in discriminating between the
interferon response and the RNAi pathway, because Sf21 cells lack
the machinery to elicit an interferon response to viral infection or
the presence of dsRNA/dsDNA-like structures in their cytoplasm.
We transfected the Sf21 RNAi sensor line with NS4B/pIB at 48 h
postinfection and analyzed the cells for GFP expression. As shown
in Fig. 3Aii, NS4B showed a significant reversion in the expression
levels of GFP, similarly to FHVB2, a known RNAi suppressor (ex-
perimental line 2 [GFP-reverted cells]). To further confirm the
RNAi suppressor properties ofNS4B,we cloned the ns4b gene into
the plant binary vector pBI121 (Fig. 3Bi) and carried out reversal
of silencing by agroinfiltration-mediated transient ectopic expres-
sion of NS4B in tobacco leaf tissues. The infiltrated leaves showed
a good amount of reversal of GFP activity at 8 days postinfiltra-
tion, while the empty control vector failed to show such a reversal
(Fig. 3Bii). The RNAi suppressor properties of NS4B were further
confirmed in a GFP-expressing mammalian sensor cell line,
HEK293T. The bicistronic vector Retro-Q, which encodes GFP
and carries a short hairpin gfp RNA, was cotransfected with either
a plasmid containing NS4B (pCDNA-NS4B) or the empty vector
alone (Fig. 3Ci). Cotransfection of the NS4B expression plasmid
dramatically restored the number of GFP-expressing cells, as was
the case with pCDNA-FHVB2, a known RNAi suppressor-ex-
pressing plasmid. However, no such reversal was observed when
only the empty control plasmid without any suppressor gene was
used (Fig. 3Cii). Expression ofNS4B in transfectedHEK293T cells
was confirmed by Western blot analysis (see Fig. 7v). Taken to-
gether, these results clearly demonstrated that the dengue virus
NS4B protein acts as a suppressor of RNAi.
FIG 1 Host RNAi regulates dengue virus replication. (Ai) Reduction in dicer, drosha, ago1, and ago2 mRNA levels at 48 h posttransfection in Huh 7 cells
transfected with the respective siRNA duplexes (#, P 0.001). (ii) TaqMan analysis of dengue virus genomic RNA in knocked-down cells at 48 h postinfection
(#, P 0.03). (iii) TaqMan analysis of WNV genomic RNA in knocked-down cells at 48 h postinfection (#, P 0.02). (B) Downregulation of mRNA levels of
dicer, drosha, ago1, and ago2 genes at 24 and 48 h postinfection in dengue virus-infected Huh 7 cells (#, P 0.05). Data shown aremeans	 standard deviations
from three independent experiments. The # symbols indicate a statistically significant difference in terms of the P value.
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FIG 2 HostmiRNA response to dengue virus infection. (A) Changes in the hostmiRNAprofile were observed upon dengue virus infection at 48 h inHuh 7 cells.
The abundance of downregulated miRNAs (1.5-fold) are presented in terms of the normalized read counts (i to iv) in both uninfected and infected samples.
(B) Validation by stem-loop qRT analysis of some of themiRNAs down- and upregulated upon dengue virus infection at 48 h (#, P 0.006). (C) Stem-loop qRT
analysis of host miRNAs that are affected upon siRNA knockdowns inHuh 7 cells (#, P 0.005). Data shown in panels B and C aremeans	 standard deviations
from three independent experiments. The # symbols indicate a statistically significant difference in terms of the P value.
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Four serotypes of DV (DV1 to DV4) have been identified so far,
andwe compared the sequences of NS4B proteins of these serotypes.
As shown in Fig. 3Di, differences were observed among the different
serotypes with respect to the NS4B protein, especially at the N and C
termini.Therefore,we tested the suppressoractivitiesofall fourNS4B
proteins in a reversal-of-silencing assay using the HEK293T cell line.
Interestingly, NS4B proteins of all serotypes showed similar RNAi
suppressor activities (Fig. 3Dii), thus advocating a conserved role of
the protein as a suppressor in the viral life cycle.
NS4B deletionmutants reveal that transmembrane domains
(TMD3 and TMD5) are responsible for RNAi suppression.
NS4B consists of 248 amino acids and contains a 23-residue signal
sequence, 2K, at its N terminus that translocates NS4B into the
lumen of the ER (2K-NS4B). The domains of NS4B and 2K-NS4B
are schematically shown in Fig. 4A. We compared the RNAi sup-
pressor activities of NS4B and 2K-NS4B in the HEK293T sensor
line. As shown in Fig. 4B, both these proteins were able to reverse
the effect of RNAi on the sensor lines of HEK293T cells effectively,
thereby suggesting that the 2K signal sequence does not signifi-
cantly influence the RNAi suppressor activity of NS4B.
DV NS4B is an integral membrane protein, and several mem-
brane topology models of NS4B predicted the presence of five
TMDs (36). To delineate the NS4B regions involved in RNAi sup-
pression, we generated several NS4B deletion mutants encom-
passing the entire length of the ns4b gene and analyzed the RNAi
suppressor activity of each mutant in a reversal-of-RNAi assay
using the HEK293T cell line. Figure 4C shows the schematics of
the deletion mutants employed in the present study. As evident
from Fig. 4D, a deletion mutant that retains only the TMD1 and
TMD2 regions (domain A) had negligible RNAi suppressor activ-
ity, while deletion mutant B, consisting of the TMD3 and TMD4
regions, and deletion mutant C, consisting of the TMD5 region,
showed RNAi suppressor activities similar to those of wild-type
NS4B. Thus, the TMD1 and TMD2 regions play no role in RNAi
suppression. This observation is noteworthy, as the N-terminal
region (domain A) of NS4B was shown previously to inhibit al-
pha/beta interferon signaling (37). Deletion of the extreme C-ter-
minal region (aa 191 to 248) of NS4B slightly affected its RNAi
suppressor activity. Together, the results of the deletion mutant
analysis showed that the TMD3 and TMD5 regions of NS4B are
required for the RNAi suppressor activity, either as an individual
unit or as a combinatorial group. Thus, the domain for the inter-
feron response is distinct from that for the RNAi suppression ac-
tivity of NS4B.
TheTMD3regionofNS4B is important for itsRNAi suppres-
sor activity. A series of substitution mutations in the ns4B gene
had previously revealed that the TMD3 region is required for virus
replication (38). To investigate the role of TMD3 in RNAi sup-
pressor activity, we further generated six substitution mutants
in the NS4B TMD3 region, namely, P104L/A, T108I/A, and
F112L/A, and confirmed their sequences with automated gene
sequencing. Figure 5A shows the location of the substitution mu-
tants generated in the present study. RNAi suppression studies
using the reversion-of-RNAi assay in a mammalian cell line were
performed with the six mutant plasmids. As shown in Fig. 5B, a
double-nucleotide modification (T340G and T341C) resulting in
the amino acid change of F112A caused a significant reduction
(40%) of RNAi suppressor activity of NS4B, while a change of
F112L did not (Fig. 5B). Expression of the F112A NS4B mutant
was also confirmed by Western blot analysis (see Fig. 7v). The
other four substitution mutations, P104L/A and T108I/A, did not
change the RNAi suppression activities of NS4B significantly (Fig.
5B). The results from a previous study (38) and the present study
together suggest that the F112A substitution in the TMD3 region
affects RNAi suppressor activity as well as viral replication.
NS4B harbors distinct domains for IFN-antagonistic and
RNAi suppressor activities. DV NS4B has been shown to inhibit
the IFN signaling cascade (23), and intriguingly, most identified
VSRs of mammalian viruses also have IFN- or protein kinase R
(PKR)-antagonistic properties that may be linked to their RNAi
suppressor function (39–41). To delineate the NS4B domains re-
quired for IFN-antagonistic activity, a HeLa cell line was trans-
fected with a firefly luciferase expression plasmid under the con-
trol of the ISRE (interferon-stimulated response element)
promoter pISRE-Luc (Agilent Technologies, Santa Clara, CA,
USA), and Renilla luciferase was used as an internal control to
normalize the transfection efficiency among all the samples (Fig.
6A). As a positive control, firefly luciferase expressionwas induced
by poly(I·C), which produces a stimulatory IFN response.
Cotransfection of a plasmid harboring ns4B alongwith pISRE-Luc
did not result in IFN-antagonistic activity. However, transfection
with 2K-NS4B resulted in a small but consistent reduction in the
luciferase expression level (Fig. 6B), thereby suggesting that the
N-terminal region of NS4B (2K region) is required for its IFN-
antagonistic activity. As the “BC” domain of NS4B did not show a
reduction of the luciferase expression level, the RNAi suppression
domain of NS4B is thus clearly distinct from the IFN-antagonistic
activity.
NS4B does not bind dsRNA.Many VSRs have been shown to
cause RNAi suppression by binding to dsRNA/siRNA (14–16,
18, 40, 42). Although NS4B has been shown to dissociate NS3
from single-stranded RNA (ssRNA), there has been no report
of its interaction with dsRNAs/siRNAs (43). To test the NS4B
activity for dsRNA/siRNA binding, we expressed the protein in
FIG 3 Reversion-of-silencing assays show that NS4B is an RNAi suppressor. (Ai) Schematic representation of plasmid constructs used for the generation of the
RNAi sensor line (experimental line 1) and the GFP-reverted cells (the RNAi sensor line that overexpressed NS4B and FHVB2) (experimental line 2). (ii) Bar
graph representation of the FACS results for FHVB2 and NS4B in the Sf21 sensor cell line, with the percentage of cells expressing GFP represented on the y axis
(*, P  0.008; #, P  0.05). (Bi) Schematic representation of plasmid construct used for overexpressing NS4B in GFP-silenced leaves of N. xanthi through
agroinfiltration. (ii) GFP fluorescence pictures of agroinfiltrated leaves at 8 dpi taken under a UV lamp. The empty vector was used as a mock control, while
FHVB2 was used as a positive control in the assay. The tested NS4B protein showed positive reversal of silencing. (Ci) Schematic representation of plasmid
constructs used for studying the suppressor activity of NS4B in a mammalian cell line (HEK293T). LTR, long terminal repeat; MSV, mouse sarcoma virus. (ii)
Bar graph representation of the FACS results for FHVB2 and NS4B in HEK293T cells, with the percentage of cells expressing GFP represented on the y axis (*,
P 0.001; #, P 0.003). (Di) Sequence alignment of NS4B proteins from all the four serotypes of dengue virus. (ii) Bar graph representation of the FACS results
for NS4B in HEK293T cells, with the percentage of cells expressing GFP represented on the y axis and the dengue virus serotype represented on the x axis. Data
shown in panels A, C, and D are means 	 standard deviations from three independent experiments. The  and # symbols indicate statistically significant
differences at a P value of0.00004.
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FIG 4 Analysis of deletionmutants for RNAi suppressor activity of NS4B. (A) Schematic representation of predicted transmembrane domains of NS4Bwith and
without its signal peptide 2K. (B) Bar graph representation of the FACS results for NS4B and 2K-NS4B in HEK293T cells, represented on the x axis, with the
percentage of cells expressing GFP represented on the y axis (#, P  0.0004). (C) Schematic representation of deletion mutants of NS4B. (D) Bar graph
representation of the FACS results for different deletionmutants ofNS4B inHEK293T cells, represented on the x axis, with the percentage of cells expressingGFP
represented on the y axis (*, P 0.0004; #, P 0.005). Data shown in panels B andD aremeans	 standard deviations from three independent experiments. The
* and # symbols indicate statistically significant differences in terms of the P value.
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a heterologous E. coli expression system. The recombinant pro-
tein was purified to apparent homogeneity and was tested for
dsRNA/siRNA binding by an electrophoretic mobility shift as-
say (EMSA). However, we did not observe any significant bind-
ing of NS4B with labeled dsRNA (Fig. 7iii), but the recombi-
nant dengue virus NS3 protein shifted the labeled dsRNA very
well in the same assay, signifying the affinity of NS3 for dsRNA.
These results suggest that NS4B suppressor activity might not
involve dsRNA binding.
NS4B inhibits Dicer processing of dsRNA into siRNA. In or-
der to explore othermechanismof RNAi suppressionmediated by
NS4B,we looked at the possibility of blockage of siRNAbiogenesis
byNS4B.Hence, we performedNorthern analysis for gfp siRNA in
GFP reversion assays with expression of either NS4B or its F112A
mutant. As observed from our results, NS4B reduced the biogen-
esis of GFP-siRNA (Fig. 7i, lane 3) whereas the F112A mutant
failed to significantly inhibit siRNA generation (Fig. 7i, lane 4).
The level of expression of the mutant NS4B protein was similar to
that of the wt NS4B protein (not shown). Hence, the in vivo re-
duction of siRNA biogenesis by NS4B seems clear.
Also, we investigated the in vitro processing of long dsRNA
substrates by dicer in the presence of NS4B and its F112Amutant.
An in vitro dicer assay was performed according to the manufac-
turer’s instructions (Genlantis, USA), in the presence of recombi-
nant NS4B F112A proteins with increasing concentrations. Figure
7iv (lane 3) reveals that 1 unit of human dicer was able to process
the dsRNA substrates into siRNAs (22 bp). However, this pro-
cessing was inhibited byNS4B in a dose-dependentmanner (lanes
5 to 8). While 1 g of NS4B protein blocked dicer processing
almost completely (lane 4), about 3 g of the F112A protein
blocked processing by not more than 10%. These results clearly
indicate that NS4B suppresses the RNAi pathway by inhibiting
siRNA biogenesis.
DISCUSSION
Increasing evidence has emerged to suggest that RNAi pathways
are the evolutionarily conserved defense mechanism against
pathogenic viral infections (3). In early reports, plant RNAi was
shown to act as a systemic antiviral defense against cytoplasmic
RNA and nuclear DNA viruses (1). As in plants, the defense func-
tion of the RNAi pathway was also shown in Caenorhabditis el-
egans and Drosophila melanogaster, where mutations in the RNAi
factor(s) showed increased susceptibility of these organisms to
infection by viruses (44). The existence of analogous systems in
vertebrates has been questioned simply because of the prevalence
of interferon-based defense mechanisms (3). Recently, a number
FIG 5 Localization of amino acid residues responsible for RNAi suppression activity of NS4B. (A) Positions of the DV2NS4Bmutations generated in this study.
Mutation sites are described as the amino acid positions in DV2 NS4B. pTMD refers to the predicted transmembrane domain. (B) Bar graph representation of
the FACS results for different mutants studied in the pTMD3 region of NS4B in HEK293T cells, represented on the x axis, with the percentage of cells expressing
GFP represented on the y axis. Data shown in panel B aremeans	 standard deviations from three independent experiments. The # symbols indicate a statistically
significant difference at a P value of0.02.
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of studies of mammalian cells have advocated the possible role of
RNAi pathways against animal viruses (3, 9, 11). Mutations in
RNAi factors or perturbations of RNAi pathways have been shown
to increase vesicular stomatitis virus (VSV), influenza A virus, and
human immunodeficiency virus type 1 (HIV-1) titers (3). In ad-
dition, HIV-1 and human T-cell leukemia virus type 1 (HTLV-1)
infections in mammalian cells cause host cell miRNA profile
changes (45), thus suggesting the role of RNAi/miRNA pathways
in viral infections. Recently, a detailed analysis of small RNA rep-
ertoires in vertebrate and invertebrate systems using six mamma-
lian RNA viruses unequivocally advocated an interplay between
viral small RNAs (vsRNAs) and virus infection in vertebrate sys-
tems (9).
Given the importance of siRNAs/miRNAs in establishing viral
infections, in the present study, we looked for the role(s) of host
miRNA/RNAi factors, especially Dicer, Drosha, Ago1, and Ago2,
in establishing dengue virus infections in mammalian cells.
siRNA-mediated knockdown of these genes resulted in significant
increases in replication of the dengue virus genome. We also ob-
served reduced mRNA levels of these genes in dengue virus type
2-infected Huh 7 cells, and similar effects were observed in the
case of WNV replication upon siRNA knockdowns. Together,
these results suggested a role of the RNAi machinery in limiting
dengue virus replication. Similar results were previously observed
in the cases of equine encephalitis virus, respiratory syncytial vi-
rus, and influenza virus (46–48). Although this is the first report of
a link between host miRNA/RNAi machineries and dengue virus
infection in a mammalian system, a number of studies have re-
ported the role of RNAi machinery in the replication of flavivi-
ruses, especially dengue virus, in insect cells (30, 31, 37). Since the
proteins Dicer, Drosha, Ago1, and Ago2 seem to be involved in
modulating dengue virus replication in human cell lines, as evi-
dent from the present study, it suggested that both siRNA- as well
as miRNA-mediated pathways may play an important role(s) in
dengue virus replication in mammalian cells.
We next analyzed the changes in miRNA profiles in dengue
virus serotype 2-infected Huh 7 cells. As observed in the cases of
human retroviruses, hepatitis B virus (HBV), HCV, and herpes-
FIG 6 Delineation of domains responsible for IFN antagonism and RNAi suppressor activity of NS4B. (A) Schematic representation of structural features of
pISRE-Luc. Upon transfection intomammalian cells (HeLa), the luciferase gene was expressed from a spliced transcript. The change in luciferase expression was
observed upon poly(I·C) treatment in the 2K-NS4B-, wt NS4B-, and BC/NS4B-transfected lines. (B) HeLa cells were cotransfected with expression vectors
encoding firefly luciferase under the control of an IFN-
-inducible promoter (pISRE-Luc) (100 ng), Renilla luciferase, and 2K-NS4B, wt NS4B, and BC/NS4B at
500 ng each in either the presence or absence of poly(I·C). Luciferase expression was measured at 31 h posttransfection. The relative luciferase expression level
corrected for the internal Renilla control (firefly/Renilla) is shown. Data shown in panel B are statistically significant at P values of0.02 () and0.05 (#).
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virus (11), we observed a considerable reduction in the human
miRNAprofile in infected cells. As the drosha anddicer levelswere
downregulated following DV infection, the reduction in the levels
of humanmiRNAs of the virus-infected cells was not very surpris-
ing. Together, these results suggest that both RNAi and miRNA
pathways probably regulate dengue virus replication and patho-
genesis in mammalian cells.
To overcome antiviral RNAi/miRNA responses, many plant,
insect, and human viruses have been shown to encode suppressor
of RNA silencing, also referred to asVSR (3, 5–7, 11). In this study,
we analyzed dengue virus NS4B for its RNAi suppressor proper-
ties. NS4Bwas selected because it has been shown to inhibit alpha/
beta interferon signaling, and a number of recent reports suggest a
link between the IFN response and RNAi machinery in regulating
viral replication inmammalian cells (3). AlongwithNS4B,we also
examinedNS4Bwith signal peptide 2K (2K-NS4B) for suppressor
activity using reversal-of-silencing assays in three independent
systems: the Sf21 line, the HEK293T line, and plant leaves that
were silenced for the expression of the reporter protein GFP. Such
transient assays have been applied successfully to identify many
plant and animal RNAi suppressors (16, 27, 33, 34). Both the
NS4B and 2K-NS4B proteins were effectively able to revert back
GFP expression in GFP-silenced lines, thereby highlighting the
role of NS4B as an RNAi suppressor in three different sensor lines.
Most importantly, NS4B proteins from all four serotypes of den-
gue virus, serotypes 1 to 4, were able to reverse RNA silencing to a
similar extent. It thus appears that NS4B-mediated characteristics
are probably conserved across the eukaryotic kingdom.
A consensus in silicomodel for the topology of NS4B suggested
that it contains five trans-membrane domains, designated TMD1,
-2, -3, -4, and -5. Furthermore, expression studies using plasmids
containing different NS4B predicted TMDs (pTMDs) fused to
enhanced GFP (eGFP) at their COOH termini showed that the
sequences containing pTMD3, -4, and -5, but not those contain-
FIG 7 NS4B inhibits the processing of shRNA/dsRNA into siRNAs both in vivo and in vitro. (i) Histogram showing levels of gfp-specific siRNA inHEK293T cells
transfected for a GFP reversion assay and Northern blot analysis of GFP siRNAs in transfected cell lines (HEK293T). Lane 1, GFP-expressing cells; lane 2,
GFP-silenced cells; lane 3, GFP-reverted cells expressing wtNS4B; lane 4, GFP-reverted cells expressing theNS4B F112A protein with rRNA loading controls. (ii)
Purification of recombinant NS4B F112A proteins run on 12% SDS-PAGE gels in increasing concentrations. (iii) EMSAs using labeled dsRNA probes with
purified NS4B protein. Lane 1, free probe; lane 2, dengue virus NS3 (1.0g); lanes 3 to 6, NS4B protein (0.1, 0.5, 1.0, and 2.0g, respectively). (iv) In vitro dicer
assay in the presence of recombinant NS4B F112A proteins in various concentrations. The purified dsRNA could be amixture of dsRNAs of various sizes, but the
majority of the dsRNAmolecules were900 bp. Lane 1, ladder; lane 2, dsRNA substrate; lane 3, control dicing reaction; lanes 4 to 11, dicing in the presence of
recombinant proteins at various concentrations (lanes 4 to 8, NS4B protein [1.0, 0.5, 0.2, 0.1, and 0.01 g, respectively]; lane 9, glutathione S-transferase [GST]
[1g]; lane 10, NS4B [1g]; lane 11, F112Amutant [3g]). The average size of the diced siRNAs was 22 bp. (v)Western analysis for expression check of NS4B
and its F112A mutant in reversal-of-silencing assays in HEK293T cells.
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ing pTMD1 and -2, mediate membrane targeting of eGFP (36).
Based on these analyses, a number of NS4B deletionmutants were
generated, and their suppression activities were analyzed. The
NS4B deletion mutants retaining pTMD3 and -5 reversed RNA
silencing to a level similar to that shown by wild-type NS4B. This
observation is significant because the NS4B anti-IFN function is
mediated by the pTMD1 and -2 regions of NS4B (35). Hence,
NS4B showed the unique characteristic of possessing distinct do-
mains for IFN antagonism and RNAi suppression.
Dengue virus NS4B has been shown to interact with the NS3
protein, and this interaction dissociates NS3 from single-stranded
RNA. Furthermore, it has been shown that a single-amino-acid
mutation in pTMD3 of NS4B (P104L), which had a pleiotropic
effect on dengue virus replication in mosquito, disrupted this in-
teraction (49). An independent study recently showed that two
mutations in the NS4B pTMD3 region (C7152U and G7165U)
attenuated the growth of wild-type DV1 and restored the replica-
tion of replication-defective dengue virus type 1 bearing a muta-
tion in the C-terminal cytoplasmic portion of NS4A (38). These
findings thus suggested that NS4B, particularly TMD3, contrib-
utes to the adaptation of DV for efficient replication. Viral repli-
cation is also linked with RNAi and its suppression. Thus, to in-
vestigate the details of the TMD3 involvement in RNAi
suppression, we generated six different substitution mutants,
P104L/A, T108I/A, and F112L/A, in the NS4B pTMD3 region and
tested the suppressor activity of these mutant proteins. Three of
these substitutions were the same as those described previously
(38), while the other three were alanine substitutions for the same
amino acids. Surprisingly, two substitution mutations, namely,
P104L and F112L, which attenuated the growth of wild-type den-
gue virus serotype 1 in Vero cells in a previous study, did not have
a substantial effect on the RNAi suppressor activity of NS4B.
However, a substitution mutation, F112A, resulted in a consider-
able loss of RNAi suppression activity. These results are consistent
with previous findings that suggested that NS4B, particularly its
TMD3 region, contributes to the adaptation of DV for efficient
replication in mammalian cells.
Experiments elaborating the mechanism of NS4B-mediated
RNAi suppression revealed interesting insights into the mecha-
nism of suppression. EMSA analysis with labeled dsRNA showed
no affinity binding of NS4B. These results suggested that NS4B
could be targeting one or a few components of the RNAi machin-
ery for inactivation. The observed reduction in biogenesis of gfp
siRNA fromGFP reversion assays in HEK293T cells suggested the
possible involvement of NS4B in dicing activity. This possibility
was substantiated by the observed inhibition of dicer activity by
NS4B in in vitro assays in a dose-dependent manner.
Furthermore, in vivo experiments revealed reduced dicer
mRNA levels upon DV infection. In addition, our data suggest
that dicer activity could also be reduced following viral infection.
Thus, DVs have evolved many counterstrategies to defeat the
RNAi-mediated host defense. It would be interesting to discover if
any other RNAi components of the host are also affected byNS4B.
In summary, three major conclusions can be drawn from this
work. RNAi/miRNA factors regulate dengue virus replication.
Dengue virusNS4B acts as a viral RNAi suppressor, and theTMD3
region of NS4B, which has been shown to be involved in viral
replication, is also important for its suppressor activity. We fur-
thermore show that the NS4B protein suppresses the RNAi re-
sponse by directly inhibiting the dicing process. As the profiles of
human miRNAs change following virus infection, the abundance
of RNAi factors might also consequently change, impacting virus
replication and propagation indirectly. Thus, the modulation of
DV replication within the human host could be due to the direct
interference of NS4B in Dicer activity as well as the indirect effects
mediated by the changes in the hostmicroRNA profiles. Although
the present study does not elaborate on the mechanism of NS4B
suppression in detail, it is clear that NS4B suppresses RNAi by
interfering with dicer activity. It is possible that NS4B might in-
teract with another host RNAi factor(s) and inhibit the biochem-
ical activities of the factor, resulting in an overall downregulation
of the host RNAi response. Nevertheless, the present study pro-
vides a lead to elucidate such mechanisms and also advocates the
development of inhibitors against NS4B so that viral replication
can be blocked by chemical means.
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